2018
DOI: 10.1177/0300060518776566
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of tacrolimus combined with glucocorticoid treatment for IgA nephropathy: a meta-analysis

Abstract: ObjectiveAs a classical immunosuppressant, tacrolimus (TAC) has been widely used in organ transplantation therapy, but the general benefits of TAC for the treatment of IgA nephropathy (IgAN) remain uncertain. We conducted a meta-analysis to examine the effects of TAC combined with glucocorticoid on IgAN.MethodsWe searched the information databases PubMed/Medline, Embase, Science Citation Index, Chinese Biomedical Literature and the Chinese databases VIP, CNKI and Wan Fang for randomized controlled trials of TA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
3

Relationship

4
6

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 36 publications
1
12
1
Order By: Relevance
“…However, TAC was the least effective at preventing the progression of IgAN, leading to more patients suffering from ESRD as well as intolerable side effects. A previous pairwise meta-analysis clearly concluded that TAC was a promising drug for IgAN without an increased risk of side effects, but these results were not exactly the same as ours 36 . That previous study did not take renal outcomes into consideration.…”
Section: Discussioncontrasting
confidence: 77%
“…However, TAC was the least effective at preventing the progression of IgAN, leading to more patients suffering from ESRD as well as intolerable side effects. A previous pairwise meta-analysis clearly concluded that TAC was a promising drug for IgAN without an increased risk of side effects, but these results were not exactly the same as ours 36 . That previous study did not take renal outcomes into consideration.…”
Section: Discussioncontrasting
confidence: 77%
“…If there was no significant heterogeneity, a weighted fixed-effect model was used. Otherwise, a random-effects model was used [21]. Heterogeneity was analysed statistically by the I 2 and Chi 2 statistics.…”
Section: Discussionmentioning
confidence: 99%
“…If there was no significant heterogeneity, a weighted fixed-effect model was used. Otherwise, a random-effects model was used [21] .…”
Section: Discussionmentioning
confidence: 99%